4 results
The main objective of this trial is to investigate safety of long term use of inhaled molgramostim by collecting information on the side effects.
To assess the effect of switching CML patients, who have been treated with imatinib *2 years and who have stable detectable molecular residual disease above 0.01% (IS), to the combination of Nilotinib and PegIFN, in terms of the proportion of…
This pilot study will evaluate the feasibility of endoscopic guided placement of gold markers in rectal cancer patients including:- Technical success of fiducial marker placement by (EUS guided) endoscopy- Visibility of fiducial markers on MRI and…
The main objective of this trial is to investigate the efficacy of inhaled molgramostim compared to placebo.